The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Park Systems' ultra-modern imaging tool (XE-Bio) gives researchers new insight into the replication process of the Hepatitis C virus. The details revealed by the XE-Bio are likely to inspire new, highly-targeted, Hepatitis C medications.
Continue reading »Developed at Texas A&M, researchers have designed a screening system that can identify which cells are infected with Hepatitis C.
Continue reading »Itching is a common symptom of Hepatitis C that goes underreported and undertreated. Instead of letting it drive you crazy, learn how home remedies and a physician's prescription pad can help ease your itching.
Continue reading »Novartis licenses alisporivir, a new drug that is currently in Phase IIb development for the treatment of Hepatitis C.
Continue reading »
Upon first glance, the Valentine's Day tradition of gifting chocolates may seem counterintuitive for someone with Hepatitis C. Though, research boasts two reasons why choosing the right kind of chocolate will show you care about your sweetheart's liver health.
Continue reading »Conatus Pharmaceuticals is optimistic that their developmental drug, CTS-1027, will give people with Hepatitis C a greater chance for beating the virus. In a Phase II Hepatitis C trial for previous non-responders, CTS-1027 is being paired with pegylated interferon and ribavirin.
Continue reading »February is American Heart Month. Since Hepatitis C has been proven to be a risk factor for coronary artery disease, the usual ways to reduce heart disease risk is insufficient for those with the virus. However, there are five strategies specifically for Hepatitis C that can reduce the likelihood of impending cardiac problems.
Continue reading »By strategically interspersing liver cells and other specialized cells on growth plates, researchers have figured out how to grow Hepatitis C outside of the body - a critical tool to develop and test new Hepatitis C treatments.
Continue reading »Slowing down efforts to prevent or cure Hepatitis C, this virus has an uncanny ability to mutate and become resistant to new drugs. By identifying compounds that interfere with Hepatitis C's replication process, scientists at Stanford University have uncovered a potentially new approach for suppressing Hepatitis C that does not appear to be vulnerable to drug resistance.
Continue reading »An isomer of PSI -7851 (a polymerase inhibitor that has already demonstrated encouraging clinical results for Hepatitis C), Pharmasset believes that PSI-7977 would be more potent and better suited for manufacturing. Hence, Pharmasset has initiated a Phase 2a trial to test this substance on treatment naïve participants with Hepatitis C genotype 1.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
